Stock listing
IMDX Stock Price, News, Filings & Events — Insight Molecular Diagnostics Inc.
Selected listing: IMDX · BOATS · USD · US
This page tracks Insight Molecular Diagnostics Inc.'s IMDX:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following IMDX:BOATS. IMDX:BOATS is the stock-level entry point for investors researching Insight Molecular Diagnostics Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Insight Molecular Diagnostics Inc. (ticker: IMDX) is a public company operating in the American market, specializing in molecular diagnostics. With a market capitalization of approximately $153 million, the company focuses on developing innovative diagnostic solutions. Their advancements aim to improve patient outcomes through precise and timely medical testing.

- Ticker
- IMDX:BOATS
- Asset type
- Stock
- Market cap
- $150.1M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- BOATS
- Currency
- USD
Insight Molecular Diagnostics Inc. IMDX:BOATS stock context
This page tracks Insight Molecular Diagnostics Inc.'s IMDX:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following IMDX:BOATS. IMDX:BOATS is the stock-level entry point for investors researching Insight Molecular Diagnostics Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Insight Molecular Diagnostics Inc. (ticker: IMDX) is a public company operating in the American market, specializing in molecular diagnostics. With a market capitalization of approximately $153 million, the company focuses on developing innovative diagnostic solutions. Their advancements aim to improve patient outcomes through precise and timely medical testing.
Research Insight Molecular Diagnostics Inc.
Insight Molecular Diagnostics Inc. investor report
Review AI stock analysis and investor report context for IMDX:BOATS.
Insight Molecular Diagnostics Inc. company profile
View the public company page for Insight Molecular Diagnostics Inc. on 6ix.
Insight Molecular Diagnostics Inc. news
Read company news and market updates connected to Insight Molecular Diagnostics Inc..
Insight Molecular Diagnostics Inc. investor events
Find investor webinars, events, and replay context for Insight Molecular Diagnostics Inc..
Alternate listings
IMDX:NASDAQ
US · USD
Alternate listing for Insight Molecular Diagnostics Inc.; the primary context on this page is IMDX:BOATS.
0KCC:LSE
GB · USD
Alternate listing for Insight Molecular Diagnostics Inc.; the primary context on this page is IMDX:BOATS.
7OC0:FWB
DE · EUR
Alternate listing for Insight Molecular Diagnostics Inc.; the primary context on this page is IMDX:BOATS.
7OC0:GETTEX
DE · EUR
Alternate listing for Insight Molecular Diagnostics Inc.; the primary context on this page is IMDX:BOATS.
7OC0:MUN
DE · EUR
Alternate listing for Insight Molecular Diagnostics Inc.; the primary context on this page is IMDX:BOATS.
7OC0:TRADEGATE
DE · EUR
Alternate listing for Insight Molecular Diagnostics Inc.; the primary context on this page is IMDX:BOATS.